eduKate Singapore

VIEW THIS AS

Auto mode follows the Route Engine until you choose a viewpoint.

YOU ARE HERE

ROUTE CHECK

CONNECTED TO

WHAT NEXT

Use the canonical route for this room, or HELP if you are unsure.

Next useful routeCanonical hubHELP

Why Study Science | Understand Antibiotic Resistance and Evolution

—

by

eduKate Asia
Original illustration of public-health procurement staff inspecting safe medicines and arranging delivery from a regional warehouse to a small island clinic.

Why study Science? Antibiotic resistance is a modern example of evolution, natural selection and genetic variation. Bacteria can acquire traits that reduce the effectiveness of specified medicines, and those traits can spread within or between populations.

Short answer: antibiotics act against bacteria rather than ordinary viruses. Resistance develops in microorganisms—not as a new ability of the human body—and can involve mutation, gene exchange and selection. Surveillance and responsible medical use are essential to understanding and managing it.

This is an educational guide, not a medical prescription. All bacterial counts and laboratory examples are invented, and real treatment decisions require a clinician. The WHO, Singapore HealthHub and SFA sources below provide the dated public-health context.

Contents

A medicine that once worked can become less effective against some bacteria

Imagine a bacterial infection for which a particular antibiotic was once routinely useful. Scientists later find that a larger share of isolates of the bacterial species can survive the drug under specified test conditions. The chemical molecule may be unchanged, but the bacterial population has changed.

This phenomenon makes antimicrobial resistance a compelling reason to study Science. It brings natural selection out of a distant history chapter and into observable differences among living microorganisms. It also requires careful understanding of genes, drug targets, laboratory measurements, public health and the distinction between a treatment and the organism being treated.

The World Health Organization’s fact sheet updated on 16 July 2026 describes antimicrobial resistance as a serious global challenge. The scientific lesson is not that medicines are worthless, but that resistance can evolve and spread when microbial populations are exposed to selective pressures.

This article is an educational explanation, not advice on whether an individual should use, start, stop or change an antibiotic. Those decisions require a qualified healthcare professional and current Singapore guidance.

Antibiotics act against bacteria, not ordinary viruses

Antibiotics are drugs used against susceptible bacterial infections. Depending on the medicine, they may target bacterial cell-wall synthesis, protein synthesis or other processes essential to bacterial survival or growth.

Viruses differ fundamentally from bacteria. They replicate within host cells and lack many bacterial structures targeted by common antibiotics. This is why Singapore’s HealthHub explains that antibiotics do not speed recovery from viral illnesses such as ordinary colds and influenza.

Symptoms such as cough, fever or coloured mucus do not reliably identify which pathogen is present. A clinician may use history, examination and relevant tests to assess whether bacterial treatment is appropriate.

Science strengthens judgement by separating the visible symptom from the underlying cause and by recognising why choosing a medicine requires more than an everyday label such as infection.

Antimicrobial resistance is broader than antibiotic resistance

Antimicrobials include antibiotics, antivirals, antifungals and antiparasitic medicines. Antimicrobial resistance describes situations in which relevant microorganisms do not respond adequately to the medicines designed to act against them.

Antibiotic resistance specifically concerns bacteria and antibacterial treatments. A drug-resistant virus and an antibiotic-resistant bacterium present different biological and clinical questions, even though both can be discussed under the umbrella of antimicrobial resistance.

The distinction matters when reading public-health articles. A headline that combines all antimicrobial classes does not necessarily report one measured rate of bacterial antibiotic resistance.

Science teaches classification by the organism and drug involved rather than by a vague impression that all germs behave alike.

Humans do not become antibiotic-resistant in the same sense as bacteria

A common statement says that a person’s body has become resistant to antibiotics after repeated treatment. More precisely, bacteria can carry traits that make a particular medicine less effective against them. Human tissues do not evolve the corresponding bacterial resistance gene during a short treatment course.

A person may carry resistant bacteria or develop an infection caused by them. That is different from the human body becoming intrinsically resistant to the drug. Singapore’s Food Agency explicitly makes this distinction in its antimicrobial-resistance educational guidance.

Correcting the wording matters because the scientific process occurs in microbial populations and can involve genetic variation, growth and transmission.

Once students know who or what is changing, they can understand why resistant bacteria can spread between people and settings.

Bacteria reproduce and generate population differences

Under suitable conditions, many bacteria divide through binary fission, increasing the number of cells. Real growth rates vary with species, nutrients, temperature and other environmental constraints.

A population is not guaranteed to consist of genetically identical cells forever. Mutations can occur as DNA is copied, while some bacteria acquire genetic information through transfers between cells or from outside sources.

These variations create differences in susceptibility to particular antibiotics. Some cells may be affected strongly, while others have characteristics that permit greater survival or growth.

Science gives students the building blocks of evolution: variation among individuals, heritable differences and changes in population composition across generations.

A mutation is a DNA change, not an intentional response

A mutation changes genetic sequence. Mutations can arise through copying errors or other processes, and their consequences vary. Many are neutral or harmful, while some can influence a bacterial trait that affects susceptibility to a medicine.

Students often imagine that bacteria recognise an antibiotic and deliberately rewrite their DNA to defeat it. The simpler natural-selection explanation is that relevant variation may already be present or arise through mutation or gene exchange, and exposure changes which variants succeed.

The antibiotic supplies a selective environment, not a conscious instruction to the bacterium. Evolution does not require microorganisms to know the purpose of a medicine.

Science teaches why an adaptive population outcome can occur without individual organisms planning the result.

Natural selection changes the proportions within a population

Suppose a mixed bacterial population contains mostly drug-susceptible cells and a smaller number with a heritable resistance trait. If the antibiotic strongly suppresses the susceptible cells while resistant cells survive and reproduce, the resistant share can increase.

The key change is in the frequency of bacterial traits across generations. Individual susceptible cells do not generally need to transform instantly into resistant ones for population-level resistance to rise.

Natural selection is one mechanism among others affecting populations; gene transfer, chance events and environmental conditions can contribute as well.

This makes antibiotic resistance an accessible, contemporary case of evolutionary Science because students can trace the consequences of differential survival.

Worked fictional selection example

Invented arithmetic model, not a laboratory culture: imagine 1,000 bacterial cells, of which 990 are susceptible to a given antibiotic and 10 have a resistant trait.

Under a simplified hypothetical treatment exposure, suppose 99 susceptible cells and all 10 resistant cells remain in the counted group. The surviving count is 109, of which 10 are resistant. The resistant fraction has increased from 1% to approximately 9.2%, although its absolute count has not increased.

This is a mathematical illustration of selection, not a prediction of how any infection responds to any antibiotic. Real antibiotic action, growth, host immunity and resistance mechanisms are much more complex.

The educational point is that a population’s percentage can rise because susceptible organisms decline, even before the resistant group reproduces.

  • Initial population: 1,000 cells.
  • Initial resistant count: 10 (1%).
  • Invented surviving susceptible count: 99.
  • Invented surviving resistant count: 10.
  • Resistant fraction among survivors: 10/109 ≈ 9.2%.
  • This is not a real dosing, efficacy or survival model.

A changing percentage is not the same as a changing number

In the fictional example, the proportion of resistant bacteria increases even though the resistant count stays at ten. A learner who reports that the antibiotic created more resistant bacteria has confused a relative change with an absolute increase.

Later reproduction could increase the resistant count, but that is an additional step. To establish it, the experiment would need appropriate measurements of numbers over time.

Science and Mathematics work together when students calculate both numerator and denominator and explain what physically changed.

The same reasoning applies to public-health rates, school experiments and any data where a group becomes a larger percentage because another group became smaller.

Resistance can sometimes be inherited by daughter cells

If a resistance-associated DNA change is stably carried through bacterial reproduction, daughter cells may inherit it. Under favourable conditions, that trait can spread through expansion of the bacterial lineage.

However, possessing a resistance gene does not always produce the same resistance level in every context. Gene expression, other genomic factors and drug conditions can influence what laboratory tests show.

A student should distinguish genetic presence, expressed mechanism and measured susceptibility. These are connected but not interchangeable levels of biological evidence.

Science trains us to ask what a genetic sequence actually does and which experiment demonstrates that function.

Bacteria can exchange genetic information

Unlike a simple family-tree model in which genes pass only from parents to offspring, bacteria can acquire some genetic material through horizontal gene transfer. Methods include transformation, transduction and conjugation.

OpenStax Biology describes these processes as important contributors to antibiotic resistance spread. A resistance-associated gene can therefore move into a different bacterial lineage under appropriate conditions.

This does not mean every bacterium can exchange every gene with any other organism or that all resistance traits transfer easily. Compatibility and cellular mechanisms matter.

Learning horizontal gene transfer expands students’ understanding of evolution beyond the simple picture of an isolated lineage accumulating mutations.

Plasmids can carry resistance-associated genes

Many bacteria contain plasmids, small DNA molecules separate from their main chromosome. Some plasmids carry genes that affect antibiotic susceptibility and can be transferred under suitable conditions.

Students may encounter cartoons showing a circular plasmid moving from one cell to another. The diagram introduces the principle, but real transfer requires particular cellular structures and environmental conditions.

Plasmids are not all resistance plasmids, and a resistance gene’s presence does not automatically predict the same phenotype in every receiving organism.

The scientific question is which gene moved, through what mechanism and with what measured consequence.

Transformation means taking up DNA

Some bacteria can take up DNA from their surroundings under suitable physiological conditions. If the acquired information becomes maintained or integrated and is functionally expressed, it may alter a trait.

A student should not imagine any fragment of environmental DNA automatically changes every nearby cell. The recipient, the DNA, the uptake state and subsequent genetic processes constrain what can happen.

Transformation illustrates how the history of an organism’s genetic information may involve material acquired beyond ordinary parent-to-offspring copying.

Science helps explain the mechanism without equating possibility with certainty.

Conjugation and transduction provide other routes

Conjugation can involve DNA transfer through cell-to-cell contact and appropriate transfer machinery. Transduction involves bacterial viruses, or bacteriophages, moving genetic material between bacteria under certain conditions.

These processes are mechanisms of genetic exchange, not instructions for students to cultivate bacteria. Their importance is that a favourable trait can spread across cells without waiting for identical mutations in each lineage.

Specialist research is needed to determine how often a given resistance element moves under particular real conditions.

Students should understand the categories conceptually while leaving microbiological manipulation to authorised laboratories.

Different resistance mechanisms have different targets

Some bacteria produce enzymes that inactivate certain antibiotics. Others modify drug targets, reduce drug entry or increase efflux through transport systems. Their effectiveness depends on the drug and the bacterium.

A useful example is beta-lactamase activity, which can break down some beta-lactam antibiotics. But the phrase ‘resistant to antibiotics’ is incomplete unless the particular agent and test result are specified.

Not all resistance involves the same molecule or pathway. A bacterium may be resistant to one antibiotic while remaining susceptible to another.

Science teaches us to name the precise interaction rather than treating resistance as one universal protective shield.

Resistance is not the same as being a more dangerous species

A resistance trait changes how a bacterium responds to a relevant antimicrobial. Virulence, which concerns the ability to cause disease and damage, is a distinct set of properties.

A resistant bacterium can be highly problematic clinically because treatment options are limited, but its resistance status alone does not automatically describe how severe every infection will be.

Researchers evaluate pathogen identity, resistance, host factors and clinical outcomes separately. Combining them into the label ‘superbug’ can conceal important details.

Science supports clear communication by differentiating treatment difficulty from other aspects of disease.

Susceptibility testing asks a defined laboratory question

Clinical laboratories can test whether a bacterial isolate is susceptible to selected antimicrobials under standardised methods. Results may be reported using categories and interpretation criteria that depend on the species, agent and relevant standards.

The minimum inhibitory concentration, or MIC, is a laboratory measure associated with the lowest concentration inhibiting visible bacterial growth under defined conditions. It is not simply the antibiotic dose a patient should take.

Different pathogens and medicines can have different breakpoints, so a raw MIC cannot be interpreted by one universal rule. Clinical decisions involve site of infection, exposure, patient factors and professional judgement.

Science students should understand what the laboratory measures while not attempting to translate those measurements into treatment plans.

An antibiogram is a population-level summary

A hospital or laboratory may summarise the fraction of tested isolates that are susceptible to particular antibiotics. Such a report is often called an antibiogram.

The result depends on which bacterial isolates were included, the patient population, the time period and the susceptibility methods. A local hospital report is not automatically a national estimate, nor does it specify the correct medicine for an individual patient.

Students can use fictional tables to practise reading a proportion while learning why surveillance requires careful sampling.

The key lesson is that population surveillance and personal clinical assessment are different kinds of evidence.

Worked example: a fictional susceptibility percentage

Invented classroom dataset: suppose 80 bacterial isolates are tested against one agent under a defined method, and 60 meet the laboratory’s specified susceptible classification.

The observed susceptible percentage is 60 ÷ 80 × 100 = 75%. The remaining 25% are not necessarily all classified resistant because an intermediate or other category may exist under the applicable testing rules.

Without information about the source population and test methods, the result does not tell us the probability that a particular person will respond to treatment.

This example develops the habit of naming a denominator, classification and setting before turning a percentage into a broad public-health statement.

Resistance surveillance depends on which cases are tested

Laboratory-confirmed infections represent a defined subset of people with symptoms or illness. Some cases are never sampled; others are tested because they are severe, recurrent or unusual, which can affect the composition of the observed dataset.

Good surveillance methods consider sampling, diagnostic capacity, changing protocols and data completeness. A high measured resistance percentage at one referral hospital may not describe every infection in the wider community.

Students should ask who was tested and why before comparing rates across settings or years.

Science protects against treating a precise percentage as self-explanatory evidence.

The WHO 2025 surveillance report needs an exact denominator

The WHO Global antibiotic resistance surveillance report 2025 analysed more than 23 million bacteriologically confirmed cases of several specified infection types from participating countries. Its findings included resistance estimates for selected pathogen–antibiotic combinations.

WHO’s July 2026 fact sheet reported that approximately one in six laboratory-confirmed bacterial infections causing common infections worldwide in 2023 were resistant to antibiotic treatments in the analysis.

This does not mean one in six of every human illness or one in six of all bacteria on Earth was resistant. It refers to a specific surveillance framework with defined organisms, infections and reporting coverage.

Scientific literacy requires quoting the population and year rather than reusing a striking statistic beyond its actual meaning.

Why the 2026 WHO update matters

The WHO fact sheet dated 16 July 2026 links antimicrobial resistance to misuse and overuse of medicines, while also noting gaps in diagnostic capacity, access and development of new treatments.

A public-health problem is not solved solely by telling individuals to use less medicine in every circumstance. Appropriate treatment must remain available when clinically needed, and prevention, diagnostics, infection control and surveillance are also important.

The goal is responsible, evidence-based antimicrobial use—not an indiscriminate refusal of antibiotics.

Science helps distinguish stewardship from denying medically necessary care.

Antibiotic treatment is sometimes essential

Antibiotics remain important for appropriately diagnosed bacterial infections. Their usefulness depends on the pathogen, medicine, patient and clinical context. Withholding necessary treatment can itself cause harm.

Public-health stewardship seeks to use an effective medicine when indicated, at an appropriate regimen determined by a qualified clinician, and to avoid unnecessary use when there is no bacterial indication.

Students should never convert a mathematical selection model into a personal decision to stop or change medication.

This topic illustrates why biological understanding and professional judgement must work together.

Why antibiotics do not treat an ordinary cold

Most common colds are caused by viruses, which do not possess the ordinary bacterial targets of antibiotics. Singapore’s HealthHub explicitly advises that antibiotics do not make viral colds or influenza resolve faster.

However, similar symptoms can occur with bacterial illnesses, and some people may experience complications requiring clinical evaluation. A symptom list cannot replace the examination, diagnosis or testing needed in a particular case.

Students should say that antibiotics are not directed against viruses rather than claim that every cough must be viral or that medical review is never needed.

Science teaches the difference between an established biological mechanism and a diagnosis.

Coloured mucus alone does not identify a bacterial infection

HealthHub notes that green phlegm is not always evidence of a bacterial infection requiring antibiotics. The colour can be influenced by white blood cells and inflammatory processes associated with various infections.

A child who reasons that green necessarily means bacterial has turned one observation into an unsupported causal conclusion. Other clinical information and sometimes tests are necessary.

This is a good diagnostic question for a Science class: what does the observation actually measure, and which alternative explanations remain?

Scientific literacy is useful because it discourages the automatic use of one visually memorable sign as a complete diagnosis.

Why prescribed doses should not be adjusted without medical advice

Singapore HealthHub advises patients to take antibiotics exactly as directed by their doctor and to consult the prescriber if they have concerns. Deliberately changing frequency or duration without advice can undermine the intended treatment and may create avoidable risk.

The correct instruction is not that every antibiotic must always be used for the longest possible course. Medical guidance can vary by illness and may be revised according to clinical evidence. Follow the actual prescription and seek advice before changing it.

Students should not infer dose, duration or drug choice from this article or from the fictional bacterial calculations.

Science supports respect for how evidence is translated into individual care.

Why sharing leftover antibiotics is inappropriate

An antibiotic suitable for one diagnosed bacterial infection may be ineffective or unsuitable for a different illness or another person’s medical circumstances. Sharing or saving medicine for an uncertain future illness bypasses diagnosis and professional selection.

HealthHub Singapore specifically advises against keeping antibiotics for future illnesses or sharing them with others, and provides guidance on returning leftovers through appropriate outlets.

The scientific reasoning is that pathogen identity, susceptibility and the medicine’s individual safety requirements differ by case.

This is a practical application of understanding microbial diversity without turning parents into medical prescribers.

Resistance can spread even without a new prescription

Resistant bacteria may pass between people, animals, food-related environments or other settings through relevant transmission routes. Once a trait exists, its spread depends on biological and environmental factors as well as antibiotic exposure.

That is why infection prevention, hand hygiene, safe food handling, sanitation and appropriate healthcare controls complement responsible prescribing.

A person should not assume that avoiding antibiotics personally makes them completely unable to encounter resistant bacteria. Transmission and population conditions also matter.

Science broadens the explanation from one patient to a network of microbial movements.

The gut microbiome can be affected by antimicrobial exposure

Many harmless or beneficial microorganisms live in and on the human body. An antibiotic may affect susceptible members of a microbial community as well as a pathogen, depending on its spectrum and where it reaches.

Different medicines and courses can have different effects on microbial communities. This does not mean every person experiences the same microbiome change or that the presence of a particular organism can be inferred from symptoms alone.

HealthHub discusses possible gastrointestinal adverse effects associated with antibiotics and encourages consultation for concerning symptoms.

Science helps explain why a medication has broader biological effects without using a simplified ecological model as personal medical advice.

Antibiotic resistance is a One Health problem

Human health, animal health and environmental conditions are connected through microbes, genes and routes of exposure. WHO and Singapore authorities use the One Health framework to address this wider system.

Singapore’s Food Agency says the government adopted a coordinated approach involving human, animal, food and environmental sectors, including a One Health Master Plan in 2025 and a second version of the national strategic action plan on antimicrobial resistance.

This provides a local example of why Science education should include ecosystems and institutions, not only one isolated laboratory cell.

Understanding interconnected systems helps students see that a public-health challenge may require multiple types of evidence and coordinated action.

Food can sometimes transmit harmful bacteria, including resistant strains. Yet a food product having been obtained from an animal treated appropriately with antibiotics does not automatically mean that a consumer’s body becomes antibiotic resistant.

Singapore’s Food Agency distinguishes drug residues in food from infection with resistant organisms and describes regulatory controls and veterinary-use requirements.

Students should not treat ‘raised without antibiotics’ as a complete food-safety certificate or assume that properly prescribed veterinary treatment is intrinsically identical to misuse.

The science task is to identify whether the claim concerns antibiotic residues, bacterial contamination, resistance genes or the overall safety of a specific product.

Veterinary treatment and responsible farming require balance

Animals can become ill from bacterial infections and may need appropriate veterinary treatment. Antimicrobial stewardship in agriculture aims to preserve effectiveness and reduce unnecessary exposure while protecting animal welfare and food safety.

SFA explains that Singapore restricts certain veterinary medicines and disallows antibiotic use for growth promotion in local farms. Required withdrawal periods are part of the food-safety system for treated animals.

Students should not conclude that every use of antibiotics in livestock is prohibited or that any antibiotic exposure creates an identical resistance outcome.

Science supports measured, regulated intervention rather than an all-or-nothing slogan.

Vaccination can reduce some infections and antibiotic demand

Vaccines can prevent certain infectious diseases or their consequences, and preventing illness can sometimes reduce situations where antibiotics would otherwise be considered or used.

The exact contribution depends on the pathogen, vaccine, coverage and clinical context. A vaccine does not replace antibiotics for every bacterial infection or make infection-control measures unnecessary.

WHO’s July 2026 AMR fact sheet identifies access to vaccines and diagnostics alongside appropriate antimicrobial use as part of the wider response.

This illustrates how preventive Biology and drug-resistance Science can reinforce one another while retaining different mechanisms.

Hygiene interrupts transmission rather than changing a resistance gene

Handwashing and suitable infection-control practices can reduce opportunities for microbes to spread. The measures do not necessarily remove resistance genes from every bacterium in one action, but they can reduce transmission of organisms carrying them.

Students should distinguish a mechanism that prevents exposure from one that changes a bacterium’s susceptibility. Both can help at the population level while acting at different points in the chain.

A systems diagram can show source, transmission, recipient and infection outcome, with hygiene inserted at the appropriate step.

Science improves public communication when it names what a preventive measure actually interrupts.

Antibiotic resistance does not always increase at one fixed rate

Resistance trends vary among species, antibiotics, countries, institutions and years. A global average or one surveillance report does not mean every bacterium is becoming more resistant by the same percentage annually.

Use of different drugs, infection-control efforts, movement of strains, genetic fitness costs and changes in sampling can affect measured rates. Some resistance frequencies may stabilise or decline under particular conditions.

Students should treat evolution as a process shaped by changing selection and population dynamics, not a graph that must rise forever.

Good scientific explanations describe the observed trend, its defined population and possible mechanisms without inventing certainty.

What a fitness cost means

Some resistance mechanisms can impose a biological cost on bacteria in environments where the antibiotic is absent, for example by altering the efficiency of a cell process. Other mechanisms may carry small costs or acquire compensating changes over time.

That means reducing selective pressure can sometimes alter relative advantages, but it does not guarantee all resistant strains vanish or all genes disappear from an environment.

Students should not use a simple competition diagram to promise an immediate reversal of resistance after a policy change.

Science teaches how natural selection depends on the environment while recognising that evolutionary history and gene exchange complicate the outcome.

Resistance, tolerance and persistence should not be merged

Resistance usually refers to the ability to grow or survive under an antimicrobial condition captured by susceptibility testing. Tolerance may describe survival through exposure without necessarily increasing a standard resistance MIC, while persistence concerns small subpopulations surviving transiently under certain conditions.

These specialised terms require careful experimental definitions. They are not all interchangeable labels for a patient feeling unwell after treatment.

A student does not need advanced laboratory procedures to learn the conceptual distinction between a growing resistant population and a temporary survival phenomenon.

This reinforces the general Science habit of defining the endpoint before comparing claims.

What researchers measure in resistance studies

Research can examine DNA sequences, known resistance genes, bacterial growth under antimicrobial exposure, susceptibility classifications and clinical outcomes. These evidence layers answer different questions.

Finding a gene associated with resistance does not automatically determine an individual treatment result. Conversely, a phenotypically resistant isolate may need further analysis to identify the underlying mechanism.

Well-designed studies report methods, control conditions, sampling and uncertainty. A headline that reports one marker without context may overstate the conclusion.

Science trains students to connect mechanism with measurement while respecting that neither alone always explains a clinical outcome.

Why new antibiotics are not an unlimited solution

Developing safe and effective antibiotics requires research, testing, regulation and appropriate clinical use. New classes and treatments are valuable, but microbial populations can develop resistance mechanisms in different ways.

WHO’s 2026 overview notes a limited research-and-development pipeline relative to the global AMR challenge. Stewardship, infection prevention and surveillance therefore remain essential even as new medicines are studied.

This does not mean that medical innovation has stopped or that future treatments are impossible. It means that a continuing biological process requires continuing scientific and public-health effort.

Science makes the challenge understandable without framing it as inevitable defeat.

A misleading analogy: bacteria are not training in a gym

People sometimes say antibiotics make bacteria stronger as if every exposed cell becomes individually more powerful through practice. The analogy suggests an intentional adaptation that misrepresents the basic natural-selection process.

A better picture is a mixed population containing variation. Under selection, some variants leave more descendants than others. Gene exchange can also transfer useful information between bacteria.

This explanation is more accurate and easier to test because it predicts changes in frequencies and identifiable traits rather than a vague increase in general strength.

Science is worthwhile because a precise mechanism often replaces an appealing but misleading metaphor.

A fictional population graph can show a misleading rise

Imagine two snapshots of a hypothetical bacterial culture with resistant counts of 20 and 25, while total counts change from 2,000 to 250. The resistant percentages rise from 1% to 10%.

The resistant absolute count rose by five, while the overall population fell dramatically. Reporting only the percentages hides that distinction; reporting only the counts misses the compositional change.

Neither snapshot reveals which antibiotic was used, whether the resistant bacteria were newly introduced or whether their genes changed. That would require additional study design and observations.

Students should calculate carefully while resisting the temptation to tell a more elaborate causal story than the table supports.

A two-week learning plan about evolution and medicines

In the first week, compare bacteria with viruses and explain why ordinary antibiotics target bacterial processes. Introduce mutation, heritable variation and natural selection, using fictional populations rather than real microbial cultures.

Next learn the conceptual routes of horizontal gene transfer and distinguish genotype, laboratory susceptibility and clinical outcome. Practise calculating resistance percentages with clearly named sample sizes.

In the second week, read WHO’s current AMR fact sheet and Singapore’s HealthHub and SFA guidance. Identify the date, population and meaning of the WHO one-in-six statistic. Finish with a claim-checking task about antibiotics for viral illnesses or an adverse reaction.

All activities should be reading, drawing and calculation tasks. Students should never culture unknown bacteria, test drugs on microbes or share personal medical information as part of this lesson.

  • Days 1–3: pathogen classes and antibiotic targets.
  • Days 4–5: variation, mutation and natural selection.
  • Days 6–7: plasmids and horizontal gene transfer.
  • Days 8–9: susceptibility measurements and denominators.
  • Days 10–11: public-health surveillance and WHO findings.
  • Days 12–13: Singapore stewardship and One Health.
  • Day 14: independently evaluate an unfamiliar resistance claim.

Questions parents can ask constructively

Ask whether the person or the bacterium acquires antibiotic resistance. If the child says medicines train bacteria to become stronger, invite them to explain how existing or newly acquired traits can be selected among a growing population.

Next ask whether a global statistic about laboratory-confirmed infections tells us the correct medicine for one patient’s illness. The answer is no; clinical diagnosis and professional advice remain necessary.

Parents can model responsible source checking by using HealthHub and WHO rather than forwarding claims about miracle cures or declaring that antibiotics are never needed.

The objective is an accurate explanation and respect for appropriate healthcare, not personal medical debate.

What this article cannot diagnose or recommend

It cannot determine whether a particular infection is bacterial, which antibiotic will work, how long a course should last or how to respond to individual symptoms or adverse effects. Those decisions depend on clinical evidence and a qualified professional.

Nor can classroom percentages predict the resistance profile of an individual patient’s pathogen. Treatment decisions should never be based on a fictional model or a global surveillance average.

Science education earns trust by making the microbial mechanisms understandable while clearly preserving the boundary between general explanation and medical care.

The lasting reason to study Science

Antibiotic resistance shows evolution in a form that directly affects modern life. Genes vary and move, populations face selective conditions and researchers measure how susceptible organisms respond over time.

A student who understands that bacteria—not human bodies—develop antibiotic resistance, and who can read a surveillance percentage with its proper denominator, has acquired a durable tool for scientific judgement.

That is why Science deserves study: it replaces vague fears and false certainty with a disciplined account of biology, evidence and responsible decision-making.

Frequently asked questions

What is antibiotic resistance?

When a bacterium has traits that reduce the effectiveness of one or more antibacterial medicines under relevant conditions.

Do people become antibiotic-resistant?

The bacteria can be resistant. A person may carry or be infected by resistant bacteria, but the human body does not become a resistant bacterium.

Do antibiotics treat viral flu or colds?

No. Ordinary antibiotics do not target viruses causing influenza or the common cold.

Can antibiotics still be necessary?

Yes. Appropriately prescribed antibiotics can be important for bacterial infections; treatment decisions belong to clinicians.

Does taking an antibiotic teach each bacterium to mutate on purpose?

No. Mutation, gene exchange and selection can change populations without conscious adaptation by individual bacteria.

What is natural selection in this setting?

A resistant trait can become more common when relevant drug exposure favours bacteria carrying it.

What is a plasmid?

A DNA molecule separate from a bacterial chromosome that may carry genes, sometimes including resistance-associated genes.

What is horizontal gene transfer?

Movement of genetic material between organisms outside ordinary parent-to-offspring inheritance, including conjugation, transformation and transduction.

Can one bacterium be resistant to one drug but susceptible to another?

Yes. Resistance mechanisms and test categories are specific to relevant bacteria and medicines.

What is an MIC?

A laboratory-defined minimum inhibitory concentration used in antimicrobial susceptibility testing under appropriate methods.

Does a susceptibility percentage choose treatment for an individual?

No. Population surveillance and clinical decisions require different evidence.

What did WHO’s 2026 AMR fact sheet report?

Approximately one in six laboratory-confirmed bacterial infections within its global 2023 surveillance context were resistant to antibiotic treatments.

Does green phlegm prove antibiotics are needed?

No. HealthHub explains that mucus colour alone does not reliably distinguish bacterial from viral illness.

Should a patient adjust antibiotic dosing on their own?

No. Follow the clinician’s instructions and consult them before changing the regimen.

Can leftovers be shared with someone else?

No. HealthHub advises against sharing or keeping antibiotics for an unrelated future illness.

Is antimicrobial resistance only a human-health issue?

No. It involves human, animal, food and environmental systems, making One Health collaboration important.

Can vaccination help reduce some antibiotic demand?

Preventing relevant infections can reduce some opportunities for antibiotic use, but the effect depends on the disease and vaccine.

Is the resistant percentage always rising everywhere?

No. Trends vary by pathogen, drug, population and conditions; results require context.

Does resistance automatically mean greater virulence?

No. Resistance and virulence are different characteristics, although resistance can complicate clinical treatment.

Should school children grow bacteria to test resistance?

No. Use fictional data and authoritative laboratory descriptions rather than cultivating unknown organisms.

WHO’s July 2026 fact sheet and its Global Antibiotic Resistance Surveillance Report 2025 describe the current global monitoring context. Singapore HealthHub and SFA explain local antimicrobial stewardship and One Health. Fictional counts are not clinical or laboratory measurements.

At eduKateSG, Science learning means correctly identifying the organism, stating the evolutionary mechanism, checking a data denominator and explaining which conclusion can be supported without offering medical advice.